SCHEMBL31455504

SCHEMBL31455504

CC(C)(C)OC(=O)N1CC(c2ccc(Nc3nc(Br)ccc3[N+](=O)[O-])cc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.40
JAK3 P52333 4/20 0.39
LCK P06239 2/20 0.39
BTK Q06187 1/20 0.39
GPR119 Q8TDV5 8/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NAMPT P43490 1/20 0.38
IGF1R P08069 1/20 0.37
JAK2 O60674 1/20 0.37
PTK2 Q05397 1/20 0.37
FPR2 P25090 1/20 0.37
KCNH2 Q12809 1/20 0.37
LMNA P02545 1/20 0.36
PTPN2 P17706 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31420326 0.85 NAMPT (0.40) JAK3LCKBTKGPR119NAMPT
SCHEMBL31455683 0.84 JAK2 (0.46) JAK3LCKBTKJAK2PTK2
SCHEMBL31454988 0.83 MAPK1 (0.43) MKNK1JAK3LCKBTKGPR119
SCHEMBL31455508 0.83 MEN1 (0.39) MKNK1JAK3LCKBTKGPR119
SCHEMBL31455266 0.82 USP30 (0.41) MKNK1ALDH1A1MAPTNAMPTIGF1R
SCHEMBL31455299 0.80 SLC34A1 (0.40) JAK3LCKBTKNAMPTIGF1R
SCHEMBL31455102 0.79 NAMPT (0.45) JAK3LCKBTKGPR119NAMPT
SCHEMBL31144608 0.79 NR1H2 (0.53) MKNK1JAK3MAPTRAB9AIGF1R
SCHEMBL10256994 0.79 JAK1 (0.42) MKNK1JAK3LCKBTKGPR119
SCHEMBL31455378 0.79 HPGDS (0.44) JAK3LCKBTKGPR119NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed